The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

In the evolving landscape of pharmaceutical production, fill-finish contract manufacturing has become a crucial area of focus ...

Q4 2024 Earnings Call Transcript March 6, 2025 Stevanato Group S.p.A. reports earnings inline with expectations. Reported EPS ...

Stevanato boosts growth with a 298% PP&E increase & 50 patents (2022-2024). Discover how innovation and high-value solutions ...